Home/Publication/InvAscent Backs API Arm of RPG Life Sciences
InvAscent Backs API Arm of RPG Life Sciences 

04 Aug 2026

US$ 20.00

InvAscent has agreed to invest up to 2.4 bn rupees (US25.5 m) in RPG Active Pharma Ltd (RPGAP), the active ......

Price / article: US$20.00
OR existing subscriber
Related Publications

KKR & Co Inc announced having raised US$19.2 bn at the final closing for its KKR Global Infrastructure Investors V ......

Integra Partners and InnoVen Capital were believed to have led the US$9 m series B funding round in PT Ottxco Menara ......

Connect With Us

We love to share Asia PE insights and news from time to time. Drop us your email address if you like to hear from us.

Rest assured that your email address will not be shared, as we hate spams as much as you do.